Evidence map›Paper›PMID 42136917›Full record

ArticleResearch and reports in urology2026

When Stones Begin: Age of Onset Reveals the Systemic Metabolic Nature of Nephrolithiasis.

Adel Alrabadi, Baha Aldeen Alshraideh, Ensaf Y Almomani, Yara Alkayed, Mamoun H Abu-Suaileek, Hamza A Alsougier, Shahd A Etoom, Ahmad Qablan, Zaina Alrabadi

Abstract read
In one paragraph

Article in Research and reports in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adel AlrabadiDivision of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan.
Baha Aldeen AlshraidehDivision of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan.ORCID 0009-0008-9293-6426
Ensaf Y AlmomaniDepartment of Basic Medical Sciences, Faculty of Medicine, Al-Balqa Applied University, Al-Salt, Jordan.
Yara AlkayedInternal Medicine Department, The University of Jordan, Amman, Jordan.
Mamoun H Abu-SuaileekFaculty of Medicine, Al-Balqa Applied University, Al-Salt, Jordan.ORCID 0009-0009-0544-6574
Hamza A AlsougierFaculty of Medicine, Al-Balqa Applied University, Al-Salt, Jordan.ORCID 0009-0009-2242-6890
Shahd A EtoomJordanian Royal Medical Services, Amman, Jordan.
Ahmad QablanDepartment of Learning and Educational Leadership, United Arab Emirates University, Al Ain, United Arab Emirates.
Zaina AlrabadiInternal Medicine Department, The University of Jordan, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Kidney stone disease is a common urological condition with a rising worldwide incidence. Although multiple metabolic and lifestyle risk factors have been identified, determinants influencing the age at which symptoms begin remain poorly defined. Understanding factors associated with earlier disease presentation may improve prevention strategies. Methods: This observational cohort study included 546 patients with confirmed nephrolithiasis. Participants were stratified into early-onset (<45 years) and late-onset (≥45 years) groups. Sociodemographic, lifestyle, clinical, urinalysis, and biochemical data were collected. Group comparisons were performed using the Chi-square test. Multivariable linear regression analyses evaluated independent associations between age of onset and clinical, laboratory, and hormonal variables. Statistical significance was set at Results: Early-onset disease accounted for 57.1% of cases. Higher body mass index, smoking, functional status, employment, and education level were significantly associated with age of onset ( Conclusion: Early-onset nephrolithiasis is strongly associated with metabolic and cardiovascular comorbidities and specific biochemical abnormalities. Age of onset may serve as a clinically meaningful marker for risk stratification and targeted preventive interventions.

Indexed as

age of onsetbiochemical risk factorscardiometabolic comorbiditiesnephrolithiasisrisk stratification

Identifiers

PMID42136917
PMCPMC13170586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.